Fri, 26 Feb 2021 13:39:41: Artiva, fresh from Merck pact, raises $120M for NK therapy R&D 

Fri, 26 Feb 2021 12:51:29: Genentech teams with academics for 10-year neuroscience R&D push

Fri, 26 Feb 2021 12:30:34: Oncolytics Bio's cancer-killing virus arms CAR-T cells to attack solid tumors in mice

Fri, 26 Feb 2021 12:18:27: Chutes & Ladders—Moderna CMO hits exit amid COVID-19 vaccine rollout

Fri, 26 Feb 2021 08:47:07: FDA tells Merck to show more data for its OncoImmune COVID-19 drug as EUA pushed back

Fri, 26 Feb 2021 08:14:08: Gossamer Bio seeking out partners for failed DP2 antagonist, says it has 'viable path forward'

Thu, 25 Feb 2021 13:36:03: Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche

Thu, 25 Feb 2021 13:25:55: Overcoming chemotherapy resistance in leukemia with a diarrhea drug from Merck

Thu, 25 Feb 2021 12:24:46: Moderna's CMO Zaks quits for 'next leg of his career' after swift move to commercial focus

Thu, 25 Feb 2021 09:21:46: GSK fails COVID-19 phase 2, subgroup finding fuels further work

Wed, 24 Feb 2021 13:23:49: UCB taps Microsoft to accelerate drug discovery, clinical trials

Wed, 24 Feb 2021 12:49:07: Xilio raises $95M to take twists on Yervoy and IL-2 into clinic 

Wed, 24 Feb 2021 11:48:39: Insights into how coronavirus changes shape could aid development of COVID-19 vaccines, drugs

Wed, 24 Feb 2021 11:23:28: The CRO megamerger is back as Icon snaps up PRA Health for $12B

Wed, 24 Feb 2021 10:43:36: Sanofi, following Denali, pens gene therapy pact with Sirion Biotech

Tue, 23 Feb 2021 13:50:18: Merck KGaA offloads clinical-phase cancer drugs to Day One

Tue, 23 Feb 2021 13:13:13: Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going

Tue, 23 Feb 2021 08:52:44: Intercept loses chief medical officer months after CEO stepped down

Mon, 22 Feb 2021 14:24:21: Genmab creates new CMO, head of experimental medicines role for Ahmadi

Mon, 22 Feb 2021 14:07:39: Amping up the immune system's T cells to improve their cancer-killing prowess

Mon, 22 Feb 2021 13:34:29: Otonomy fails phase 3, adding another twist to ear disease saga

Mon, 22 Feb 2021 11:53:49: After setback, Sanofi, GSK take tweaked COVID-19 vaccine into phase 2

Mon, 22 Feb 2021 09:42:59: Daiichi Sankyo poaches Kite's research lead Takeshita from parent Gilead

Fri, 19 Feb 2021 14:44:55: Precision's one-time gene editing treatment lowers cholesterol in monkeys for 3 years

Fri, 19 Feb 2021 13:27:10: As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing